Title : Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.

Pub. Date : 2007 May

PMID : 17448179






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The percentage of patients reporting 2-h pain relief was significantly greater for rizatriptan than for placebo (MM1 70% vs. 53%, MM2 73% vs. 50%), as was the percentage of patients reporting 24-h sustained pain relief (MM1 46% vs. 33%; MM2 46% vs. 33%). rizatriptan plexin B2 Homo sapiens